artenimol has been researched along with Congestive Ophthalmopathy in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sha, X; Wang, X; Xiao, W; Xu, Z; Yang, H; Yang, S; Ye, H | 1 |
1 other study(ies) available for artenimol and Congestive Ophthalmopathy
| Article | Year |
|---|---|
Dihydroartemisinin Exerts Antifibrotic and Anti-Inflammatory Effects in Graves' Ophthalmopathy by Targeting Orbital Fibroblasts.
Topics: Anti-Inflammatory Agents; Artemisinins; Cells, Cultured; Fibroblasts; Fibrosis; Graves Ophthalmopathy; Humans; Hyaluronic Acid; Inflammation; Transforming Growth Factor beta1 | 2022 |